Health · Healthcare & Policy · 3 hrs ago
UK watchdog bans Voy test kit adverts over low testosterone claims
The UK advertising watchdog banned adverts for Voy's at-home testosterone tests over claims about low testosterone.
The Advertising Standards Authority said the adverts overstated links between the condition and common symptoms such as low energy, mood changes and low sex drive.
It also found no evidence for the claim that low testosterone affects one in four men over 30.
These symptoms can have many possible causes, so they should not be presented alone as strong signs of low testosterone.
The ruling is part of a wider investigation into adverts targeting men's health concerns, including earlier decisions about adverts from BioID Health and Numan Digital Healthcare.
Companies can still advertise these tests, but their claims must be accurate and supported by evidence.
Voy's chief medical officer said the company keeps its advertising under review to meet UK standards.
The UK Advertising Standards Authority banned adverts for Voy’s at-home testosterone test kit over claims linking common symptoms to low testosterone.
The watchdog said the adverts exaggerated the connection between symptoms that can have many possible causes and the condition.
It also found a Facebook advert’s claim that low testosterone affects one in four men over 30 was misleading and unsupported by evidence provided by Voy.
Voy’s chief medical officer said the campaigns were developed to align with UK advertising standards and that the company continually reviews its advertising.
The ruling followed two similar ASA rulings in August and forms part of a wider investigation into adverts targeting men concerned about their health.
- Who
- The Advertising Standards Authority ruled against adverts for Voy’s test kit.
- What
- The watchdog banned the adverts over claims about symptoms of low testosterone and the prevalence of the condition.
- When
- Wednesday; the article was published on 18 November 2026.
- Where
- The United Kingdom.
- Why
- The ASA said the adverts exaggerated links between common symptoms and low testosterone and included a prevalence claim that was misleading and unsupported by evidence.
Advertising Standards Authority
Voy
Claims and standards
Advertising Standards Authority
The ASA said the adverts exaggerated links between common symptoms and low testosterone, and that a claim about one in four men over 30 was misleading and unsupported by evidence.
Voy
Voy’s chief medical officer said the campaigns were developed to align with UK advertising standards and that Voy continually reviews its advertising.
The ASA found misleading claims in adverts for testosterone testing services from BioID Health and Numan Digital Healthcare.
The ASA ruled against Voy’s adverts, citing exaggerated symptom links and an unsupported claim about prevalence among men over 30.
- Regulator
- Advertising Standards Authority
- Company
- Voy
- Claim in advert
- Low testosterone affects 1 in 4 men over 30
- Symptoms cited
- Low sex drive, low energy, loss of motivation and changes in mood
- Previous rulings
- August rulings involving BioID Health and Numan Digital Healthcare
What people are saying
While some symptoms may be more closely associated with the condition, others were much less specific and shouldn't have been presented as strong indicators of low testosterone in isolation
Every patient decision at Voy is clinician-led and these campaigns were developed to align with UK advertising standards. We keep all our advertising under continual review to ensure it meets any updated guidance.
It's very easy to get a low testosterone level in any healthy man, simply by doing a blood test in the afternoon, after a meal, when unwell from any cause, or after an all-night sit up.